Примери за използване на Dose reductions на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Possible dose reductions.
Dose reductions are not recommended for Perjeta.
If recurrence after irinotecan and 5-FU dose reductions.
No dose reductions are recommended.
Common terminology criteria for adverse events Table 4- Dose reductions according to body surface area(BSA).
No dose reductions are recommended.
Few patients required dose interruptions or dose reductions(0.7% or 2/274).
No dose reductions are recommended.
Dosage adjustments during treatment No dose reductions of MabThera are recommended.
No dose reductions of Ritemvia are recommended.
Not recommended because appropriate dose reductions cannot be achieved with the combination tablet.
No dose reductions are recommended(see sections 4.4 and 5.1).
Regarding safety, side effects are generally manageable with dose reductions.
FOLFIRI dose reductions FOLFIRI componenta.
Use lowest dose of eltrombopag as necessary to avoid dose reductions of peginterferon.
Two dose reductions were required in 41% of patients.
The most frequent adverse reactions(≥3%)associated with dose reductions were elevated transaminases and neutropenia.
Two dose reductions were required in 19.3% of patients.
When Rituzena is given in combination with chemotherapy, standard dose reductions for the chemotherapeutic medicinal products should be applied.
The dose reductions can be temporary or permanent.
Anaemia was managed with dose interruptions and dose reductions(see section 4.2), and where appropriate with blood transfusions.
For dose reductions due to other toxicity, see section 4.4.
Peripheral neuropathy led to treatment discontinuation in 7%, dose reductions in 21%, and dose delays in 1% of patients.
Dose reductions are not recommended for Perjeta or trastuzumab.
Serum concentrations Dose reductions of colchicine may be required.
Dose reductions may be implemented based on adverse reactions.
No patients had dose reductions due to hyperglycaemia.
Dose reductions are recommended for patients with creatinine clearance< 50 ml/min.
Other potent inhibitors of CYP2D6, such as fluoxetine and paroxetine, may be expected to have similar effects and similar dose reductions should therefore be applied.
Recommended dose reductions are indicated in Table 1.